Gianluca Trifirò
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief

Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
About the journal
Start your submission and get more impact for your research by publishing with us.

Ready to publish? Check our author guidelines for everything you need to know about submitting, from choosing a journal and section to preparing your manuscript.

Reviewing a manuscript? See our editor guidelines for everything you need to know about the Frontiers peer review process.

Our rigorous and transparent peer review combines expert assessment with constructive dialogue to strengthen your manuscript.

Article processing charges apply to articles accepted for publication by our external editors after rigorous peer review.
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief
University of Florence
Italy
Specialty Chief Editor
Substance-Based Medical Devices
University of Bern
Switzerland
Specialty Chief Editor
Maternal-Fetal Medicine
Netherlands Pharmacovigilance Centre Lareb
Netherlands
Specialty Chief Editor
Vaccine Safety and Regulation
University of Milano-Bicocca
Italy
Specialty Chief Editor
Pharmaceutical Policy and Regulation
University of Pisa
Italy
Specialty Chief Editor
Clinical Drug Safety
Harvard Medical School and Harvard Pilgrim Health Care Institute
United States
Specialty Chief Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
University of Salerno
Italy
Associate Editor
Substance-Based Medical Devices
99 editors · 0 reviewers
Drug Safety and Regulation
Published
Jeannie K. Lee · J. Skye Nicholas · Amani Albadawi · Kathleen C. Insel
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1476998
Drug Safety and Regulation
Published
Deborah Layton · Laura Hester · Asieh Golozar
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1579171
Open for submissions
Open for submissions
Open for submissions
El alcance incluye estudios de farmacovigilancia, análisis de datos de reacciones adversas, legislación y regulación de productos biológicos y biosimilares, errores de medicación, farmacoeconomía orientada a la seguridad y políticas de aprobación acelerada o condicional de fármacos.
Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/advanced-methods-in-pharmacovigilance-and-pharmacoepidemiology
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/clinical-drug-safety
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/maternal-fetal-medicine
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/pharmaceutical-policy-and-regulation
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/substance-based-medical-devices
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/vaccine-safety-and-regulation
Fees are charged only after acceptance. Waivers and discounts are available for authors with limited funding.
Fees and waivers policyInternal metrics, calculated on this platform and maintained by the editorial office.
Source: official publisher page · retrieved 2026-10-16
Some values were updated by the editorial office on 2026-10-21.